• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

A New Study Claims A Weight Loss Wonder Drug Might Be Useful In Treating Obesity Among People

May 28, 2021 by Jennifer Preston Leave a Comment

Experts have said that a weight loss wonder medicine, which is given to reduce calorie intake and curb appetite and cravings might be useful in treating obesity. A new study has revealed that a drug called semaglutide, might help fight against the country’s obesity crisis. The authors of the study have said that patients, who have been enrolled in the study, have been given the jab on weekly basis. They have been able to lose a tenth of their total body weight in just 20 weeks that is 25 times higher as compared to patients who have been given a placebo. Semaglutide is known to reduce calorie intake by more than a third. The study has noted that patients who have received semaglutide jabs have reported having fewer hunger pangs. These patients have felt fuller quite faster and have been eating 35 percent fewer calories when they have been given an opportunity to eat unlimited free lunch. The drug is being used in the treatment of type 2 diabetes as well. Experts have said that the drug takes control over the appetite-regulating system of the body. As per the report, a month’s supply of the drug costs around $73. The findings of the study are going to be presented at the European Congress on Obesity.

The study has enrolled around 72 people who have been dealing with obesity. They have been in the age range of 18 to 65 years. The study has been done by experts from a drug manufacturing firm called Novo Nordisk. Around half of the patients have been given a jab and others have been kept on placebo during the study. Experts have done a survey on their eating habits and their appetite at the initial stage of the study. The same kind of survey has been done after 20 weeks as well. Scientists have scheduled a set breakfast for all participants of the study followed by an unlimited free lunch after a gap of 5 hours. Experts have found that patients who have been given the drug have been eating 1736 calories during their lunchtime. It has been 940 calories fewer than the patients who have been given a placebo. The study has shown that people who have been given the jab have lost 9.9 percent of their body weight on average. People who have been given a placebo have been able to lose only 0.4 percent of their body weight on average. People who have been on this drug have said that they have been able to control their hunger in a much better way.

The authors of the study have said that a dose of 1 mg of the jab is given to treat type 2 diabetes, while the new trial has used around a dose of 2.4 mg of the drug. As per the report, the drug has not been authorized for use in severe weight management treatment anywhere across the world. However, the drugmaker has submitted the application for approval. Health authorities are reviewing the application. It shows that the drug might available soon for use on the National Health Service (NHS). Dr. Dorthe Skovgaard, who is one of the authors of the study, has said that a dose of 2.4 mg of semaglutide has been able to suppress calorie intake and reduce frequent food cravings among the participants. Earlier, a study has revealed that patients who have been given treatment with this drug have been able to lose around 14.9 percent of their body weight in just one year. Dr. Tam Fry from the National Obesity Forum has said that the drug is a boon for obesity specialists around the world. The data have shown that nearly two in three adults living in the UK are overweight or dealing with obesity. It shoots up their risk of being diagnosed with cancer, heart disease, and type 2 diabetes.

Jennifer Preston
Jennifer Preston

Related posts:

  1. A New Study Shows People With Sedentary Lifestyle Are At A Higher Risk Of Death Due To COVID19
  2. A Global Study Reveals COVID19 Infection Might Cause Stroke In Healthy And Young People
  3. A New Study Reveals 5 Servings Of Fruits And Vegetables Help People Live Longer
  4. A New Study Reveals 5 Servings Of Fruits And Vegetables Help People Live Longer

Filed Under: Health

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Why Do Lion Cubs Have Spots?
  • 80 Years On, Chilling Photos Of The Hiroshima Bombing Remind Us Why Nuclear Weapons Are Terrifying
  • Four Radioactive Wasp Nests Have Been Found At A Nuclear Facility In South Carolina
  • Ancient Burial Practices
  • Why Do Arms And Legs “Fall Asleep”?
  • Anatoli Bugorski: The Man Who Put His Head In A Particle Accelerator And Survived
  • Alpha Centauri A – Our Closest Sun-Like Star – Has A New “Very Strong Candidate” Planet
  • Redditors Claim They Can Smell When Someone Is Pregnant. Is That Really A Thing?
  • New Monster Black Hole 36.3 Billion Times Our Sun May Be “Most Massive” Ever Found
  • An Interstellar Mission To Visit A Black Hole Might Only Take 70 Years, Astrophysicist Says
  • Four Super Rare Barbary Lion Cubs Born At Czech Zoo In Conservation Win
  • NASA’s Perseverance Snaps One Of Sharpest 360° Panoramas On Mars Ever Taken
  • UAP Researchers Search For “Transient Events” In Earth’s Shadow, Finding Unexplained Events
  • Neolithic Cannibals In Spain Ate Their Enemies As A Form Of “Ultimate Elimination”
  • RFK Jr Pulls Millions Of Dollars Of mRNA Vaccine Funding, Citing Misinformation – Here’s What To Know
  • Ride On Board A Red-Footed Booby As It Catches Flying Fish Above The Indian Ocean
  • People Returned To Live In Post-Apocalyptic Pompeii – But Life Was Never The Same
  • Keep An Eye Out For Aurorae This Week – This “Weak” Solar Flare Might Pack A Surprising Punch
  • Are You More Likely To Be Killed By An Elephant Or An Asteroid? Science Now Has The Answer
  • Five Times A Tumor Behaved Downright Weird
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version